SCHEMBL3418015

SCHEMBL3418015

Brc1nncn1-c1ccc(C2CC2)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC22A12 Q96S37 18/20 0.47
CYP2C9 P11712 4/20 0.47
CYP2C19 P33261 3/20 0.47
CYP3A4 P08684 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
SLC22A11 Q9NSA0 1/20 0.47
SLC2A9 Q9NRM0 2/20 0.39
HCAR1 Q9BXC0 1/20 0.31
DRD2 P14416 1/20 0.31
SLC6A4 P31645 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29362515 0.83 SLC22A12 (0.40) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL17069753 0.83 SLC22A12 (0.41) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL5524129 0.83 SLC22A12 (0.40) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL23022609 0.80 SLC22A12 (0.43) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL21750609 0.79 SLC22A12 (0.64) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL19867947 0.75 SLC22A12 (0.41) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL28036200 0.74 SLC22A12 (0.40) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL27951684 0.74 SLC22A12 (0.43) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL1299921 0.73 SLC22A12 (0.58) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2
SCHEMBL10226525 0.73 SLC22A12 (0.58) SLC22A12CYP2C9CYP2C19CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2217577-A2 NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE Ardea Biosciences, Inc. (US) 2010-08-18 EP claimed
WO-2009070740-A2 NOVEL COMPOUNDS AND COMPOSITIONS AND METHODS OF USE ARDEA BIOSCIENCES INC. (US) 2009-06-04 WO claimed
EP-3281941-B1 PROCESS FOR PREPARING 2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID ZENTIVA KS (CZ) 2019-07-24 EP disclosed
EP-3281941-A1 PROCESS FOR PREPARING 2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETIC ACID Zentiva K.S. (CZ) 2018-02-14 EP disclosed